• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Tuesday 09/18/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

USPTO

  • 1:38 PM

    NEW YORK, Oct. 05, 2017, AXIM, (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (AXIM® Biotech), (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 14/982,610, a patent that claims the use of an ophthalmic solution comprising cannabinoids for the treatment of glaucoma and symptomatic relief of conjunctival inflammation. A Notice of Allowance is issued after the USPTO makes a determination that a

    Read more
  • 6:11 PM

    LAS VEGAS, Dec. 13, 2016, GBLX, /PRNewswire/ — GB Sciences, Inc. (OTCQB: GBLX) is pleased to announce that its wholly-owned subsidiary, Growblox Life Sciences, LLC has licensed intellectual property from Makai Biotechnology, LLC. The patent underlying the license was issued by the USPTO in July of 2015, and claims therapeutic methods for the treatment of cardiac hypertrophy and associated pathologies through regulation of the cannabinoid receptor, TRPV1. TRPV1 can be regulated therapeutically by plant-based cannabinoids, which creates a plethora of

    Read more
  • 4:27 PM

    SALT LAKE CITY, Nov. 29, 2016, GBSN, (GLOBE NEWSWIRE) — Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced that the United States Patent and Trademark Office (USPTO) issued U.S. Patent 9,434,999 for the company’s amplification suppressor. This technology blocks detection of contaminants present in the environment that may result in a false positive result and potential misdiagnosis of a patient. The high sensitivity of molecular diagnostic testing makes it vulnerable to the influence of common environmental contaminants

    Read more
  • 5:31 PM

    ROCKVILLE, Md., Nov. 2, 2016, RGRX, /PRNewswire/ — RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for a single unit dosage eye drop formulation containing Thymosin beta 4 (Tβ4). Tβ4 is the active pharmaceutical ingredient in RGN-259, RegeneRx’s preservative-free eye drops currently in Phase 3 clinical trials. Claims covered

    Read more
  • 3:05 PM

    VANCOUVER, BC–(Marketwired – August 05, 2016) – Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today that it has filed an international patent application with the US Patent & Trademark Office (USPTO) that covers transdermal extended-release formulations of doxylamine succinate and pyridoxine hydrochloride in combination, relating to the Company’s AQS1303 program to treat pregnant women experiencing nausea and vomiting. This is

    Read more
  • 3:24 PM

    STUART, FL— ESPH, (Marketwired – March 08, 2016) – Ecosphere Technologies, Inc. (OTCQB: ESPH), a technology development and intellectual property licensing company, today announced that the United States Patent and Trademark Office (USPTO) has approved a 14th United States Patent for Ecosphere’s multi-patented OZONIX® Advanced Oxidation Process (AOP) technology. On February 23, 2016, the USPTO approved U.S. Patent # 9,266,752, which relates to the field of fluid treatment and specifically an improved treatment apparatus for destroying aerobic and anaerobic bacteria

    Read more
Public Wire Banner